WATCH LIVE: CDC, FDA to discuss Johnson & Johnson vaccine

A joint media briefing with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a rare type of blood clot in individuals who received the J&J COVID-19 Vaccine is scheduled to begin at 10 am. The call is audio-only.